510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K192239Substantially Equivalent

WavelinQ Plus EndoAVF System

C.R. Bard Inc, Tempe AZ / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)510(k) summary (opens on fda.gov)

K192239 is the FDA 510(k) clearance record for WavelinQ Plus EndoAVF System, a class II device, cleared for C.R. Bard, Inc. on under FDA product code PQK (Percutaneous Catheter For Creation Of An Arteriovenous Fistula For Hemodialysis Access). FDA's definition for product code PQK reads: "Percutaneous catheter for creation of an arteriovenous fistula for hemodialysis access. This device is a single use percutaneous catheter system that creates an arteriovenous fistula in the arm of patients with chronic kidney disease who...". FDA records list 646 510(k) clearances for C.R. Bard, Inc., from to . As of , FDA records show one recall naming K192239.

Clearance record

Decision date
Received
(59 days to decision)
Product code
PQK Percutaneous Catheter For Creation Of An Arteriovenous Fistula For Hemodialysis Access
Regulation
21 CFR 870.1252
Device class
Class II
Review panel
Cardiovascular
Applicant
C.R. Bard, Inc. 1625 W. 3rd St., Tempe AZ
510(k) summary
Summary PDF
Third party review
No

Clearances, product code PQK

Trailing 12 months

FDA records hold no clearances under product code PQK in the trailing twelve months.

FDA records show no clearances under product code PQK in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code PQK, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260